csirt@kutim:~/threat-intel/cve/CVE-2025-13516

Katalog CVE

CVSS 8.1 · High EPSS 0,97%

Kerentanan Unrestricted Upload of File with Dangerous Type. Skor CVSS 3.1 8.1 (High) menurut wordfence.com.

Deskripsi (NVD)

The SureMail – SMTP and Email Logs Plugin for WordPress is vulnerable to Unrestricted Upload of File with Dangerous Type in versions up to and including 1.9.0. This is due to the plugin's save_file() function in inc/emails/handler/uploads.php which duplicates all email attachments to a web-accessible directory (wp-content/uploads/suremails/attachments/) without validating file extensions or content types. Files are saved with predictable names derived from MD5 hashes of their content. While the plugin attempts to protect this directory with an Apache .htaccess file to disable PHP execution, this protection is ineffective on nginx, IIS, and Lighttpd servers, or on misconfigured Apache installations. This makes it possible for unauthenticated attackers to achieve Remote Code Execution by uploading malicious PHP files through any public form that emails attachments, calculating the predictable filename, and directly accessing the file to execute arbitrary code granted they are exploiting a site running on an affected web server configuration.

Rincian

Terbit di NVD
2 Desember 2025
Terakhir diubah
17 Juni 2026
Status NVD
Deferred
CVSS 3.1
8.1 (High), sumber wordfence.com
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-434: Unrestricted Upload of File with Dangerous Type
EPSS (30 hari)
0,97% peluang dieksploitasi; lebih tinggi dari 60,7% CVE lain

Produk dan versi terdampak

NVD belum mencantumkan data produk (CPE) untuk CVE ini. Produk yang terdampak biasanya disebut di deskripsi dan di advisory vendor pada daftar referensi.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.